Clinical Trial Update: Efficacy of Cognitive Remediation in Patients With Schizophrenia or Schizoaffective Disorder Stabilized on Lurasidone [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating cognitive remediation in schizophrenia or schizoaffective disorder patients stabilized on lurasidone has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: New York State Psychiatric Institute | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2017-04-11